Edarbi Side Effects

Generic name: azilsartan medoxomil

Medically reviewed by Drugs.com. Last updated on Mar 24, 2025.

Note: This document provides detailed information about Edarbi Side Effects associated with azilsartan medoxomil. Some dosage forms listed on this page may not apply specifically to the brand name Edarbi.

Applies to azilsartan medoxomil: oral tablet.

Important warnings This medicine can cause some serious health issues

Oral route (tablet)

Discontinue use of azilsartan medoxomil as quickly as possible if pregnancy is detected as drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.

Common side effects of Edarbi

Some side effects of azilsartan medoxomil may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common side effects

• diarrhea

Rare side effects

• cough
• dizziness
• lack or loss of strength
• muscle spasm
• nausea

Serious side effects of Edarbi

Along with its needed effects, azilsartan medoxomil (the active ingredient contained in Edarbi) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking azilsartan medoxomil:

Rare side effects

• blurred vision
• confusion
• dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
• sweating
• unusual tiredness or weakness

For healthcare professionals

Applies to azilsartan medoxomil: oral tablet.

General adverse events

The most common side effects were diarrhea, dizziness, headache, dyslipidemia, cough, and increased blood creatine phosphokinase.^[Ref]

Gastrointestinal

• Common (1% to 10%): Diarrhea
• Uncommon (0.1% to 1%): Nausea^[Ref]

Nervous system

• Common (1% to 10%): Dizziness, headache
• Frequency not reported: Dizziness postural^[Ref]

Metabolic

• Common (1% to 10%): Dyslipidemia
• Uncommon (0.1% to 1%): Blood uric acid increased, hyperuricemia^[Ref]

Respiratory

• Common (1% to 10%): Cough^[Ref]

Musculoskeletal

• Common (1% to 10%): Blood creatine phosphokinase increased
• Uncommon (0.1% to 1%): Muscle spasm^[Ref]

Dermatologic

• Uncommon (0.1% to 1%): Rash, pruritus
• Rare (less than 0.1%): Angioedema^[Ref]

Other

• Uncommon (0.1% to 1%): Fatigue, peripheral edema
• Frequency not reported: Asthenia^[Ref]

Hematologic

• Uncommon (0.1% to 1%): Low hemoglobin, low hematocrit, low RBC counts^[Ref]

Renal

• Uncommon (0.1% to 1%): Blood creatinine increased^[Ref]

Cardiovascular

• Uncommon (0.1% to 1%): Hypotension^[Ref]

Further information

Edarbi side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer